| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |